{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:PDE",
      "entity_text" : "phosphodiesterase",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:145068",
      "entity_text" : "nitric oxide",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "All nitric oxide potentiating drugs (e.g., phosphodiesterase type 5 inhibitors) were suspended for 1 week, and all antihypertensive and vasoactive drugs, alcohol, and caffeine were held for at least 12 h before vascular function measurements.",
  "reading_complete" : "2020-07-28T12:45:13Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T12:42:19Z",
  "trigger" : "potentiating",
  "evidence" : [ "nitric oxide potentiating drugs (e.g., phosphodiesterase" ],
  "pmc_id" : "3836144",
  "score" : 0
}